"Unnamed: 0","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","13/78","108/10891",5.52660067252027e-13,1.78509201722405e-10,1.47763849560016e-10,"CKAP4/CSF1/CST3/FGF23/FSTL1/FSTL3/IGFBP4/IGFBP7/IL6/LGALS1/SHISA5/SPP1/TIMP1",13
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","13/78","125/10891",3.73644615810045e-12,6.03436054533222e-10,4.99503854819744e-10,"CKAP4/CSF1/CST3/FGF23/FSTL1/FSTL3/IGFBP4/IGFBP7/IL6/LGALS1/SHISA5/SPP1/TIMP1",13
"R-HSA-159740","R-HSA-159740","Gamma-carboxylation of protein precursors","4/78","10/10891",4.94817615783905e-07,3.99565224745503e-05,3.30746511602926e-05,"BGLAP/F10/F7/PROS1",4
"R-HSA-159782","R-HSA-159782","Removal of aminoterminal propeptides from gamma-carboxylated proteins","4/78","10/10891",4.94817615783905e-07,3.99565224745503e-05,3.30746511602926e-05,"BGLAP/F10/F7/PROS1",4
"R-HSA-159854","R-HSA-159854","Gamma-carboxylation, transport, and amino-terminal cleavage of proteins","4/78","11/10891",7.73346222693807e-07,4.99581659860199e-05,4.1353671697732e-05,"BGLAP/F10/F7/PROS1",4
"R-HSA-5669034","R-HSA-5669034","TNFs bind their physiological receptors","5/78","29/10891",1.71810795911598e-06,9.24914784657438e-05,7.65613020378e-05,"EDA2R/TNFRSF14/TNFRSF1A/TNFRSF4/TNFRSF9",5
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","7/78","102/10891",7.87193332868906e-06,0.000363233495023795,0.00030067234067474,"EDA2R/LTBR/TNFRSF12A/TNFRSF14/TNFRSF1A/TNFRSF4/TNFRSF9",7
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","5/78","47/10891",2.0068816582413e-05,0.000810278469514927,0.000670720975254331,"CD80/CSF1/IL6/TIMP1/TNFRSF1A",5
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","10/78","300/10891",5.19293514797638e-05,0.0018636867253293,0.0015426965234924,"AGRN/COL18A1/COL6A3/ELN/FBLN2/HSPG2/LTBP2/LTBP3/SPP1/TIMP1",10
"R-HSA-2129379","R-HSA-2129379","Molecules associated with elastic fibres","4/78","37/10891",0.000134375075908708,0.00434031495185126,0.00359276518745387,"ELN/FBLN2/LTBP2/LTBP3",4
"R-HSA-3560782","R-HSA-3560782","Diseases associated with glycosaminoglycan metabolism","4/78","41/10891",0.00020162255327683,0.005772671017469,0.00477842085200302,"AGRN/CSPG4/HSPG2/OGN",4
"R-HSA-163841","R-HSA-163841","Gamma carboxylation, hypusine formation and arylsulfatase activation","4/78","42/10891",0.000221641283233884,0.005772671017469,0.00477842085200302,"BGLAP/F10/F7/PROS1",4
"R-HSA-9006936","R-HSA-9006936","Signaling by TGFB family members","6/78","122/10891",0.000232336604418257,0.005772671017469,0.00477842085200302,"ACVRL1/FSTL1/FSTL3/LTBP2/LTBP3/TGFBR2",6
"R-HSA-1566948","R-HSA-1566948","Elastic fibre formation","4/78","44/10891",0.00026591330337383,0.00613499978498193,0.00507834428999645,"ELN/FBLN2/LTBP2/LTBP3",4
"R-HSA-216083","R-HSA-216083","Integrin cell surface interactions","5/78","85/10891",0.000347237524870837,0.00662206437272787,0.00548151980013974,"AGRN/COL18A1/COL6A3/HSPG2/SPP1",5
"R-HSA-3560783","R-HSA-3560783","Defective B4GALT7 causes EDS, progeroid type","3/78","20/10891",0.00036903145111177,0.00662206437272787,0.00548151980013974,"AGRN/CSPG4/HSPG2",3
"R-HSA-3560801","R-HSA-3560801","Defective B3GAT3 causes JDSSDHD","3/78","20/10891",0.00036903145111177,0.00662206437272787,0.00548151980013974,"AGRN/CSPG4/HSPG2",3
"R-HSA-4420332","R-HSA-4420332","Defective B3GALT6 causes EDSP2 and SEMDJL1","3/78","20/10891",0.00036903145111177,0.00662206437272787,0.00548151980013974,"AGRN/CSPG4/HSPG2",3
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","4/78","51/10891",0.000471303581744695,0.00786664502562202,0.00651174136062569,"EFNA1/EFNA4/EPHA2/EPHB4",4
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","6/78","140/10891",0.00048709876319641,0.00786664502562202,0.00651174136062569,"COL18A1/COL6A3/ELN/HSPG2/SPP1/TIMP1",6
"R-HSA-1971475","R-HSA-1971475","A tetrasaccharide linker sequence is required for GAG synthesis","3/78","26/10891",0.000816033970974039,0.0125513796487912,0.0103896054449827,"AGRN/CSPG4/HSPG2",3
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","3/78","30/10891",0.00124831628604831,0.0183275527451639,0.0151709251988647,"EFNA1/EFNA4/EPHA2",3
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","4/78","78/10891",0.00232525378637259,0.0326546509999281,0.0270304101482214,"CD28/CD80/FGF23/HGF",4
"R-HSA-140877","R-HSA-140877","Formation of Fibrin Clot (Clotting Cascade)","3/78","39/10891",0.00268304850328364,0.0361093611066923,0.0298901017471072,"F10/F7/PROS1",3
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","2/78","12/10891",0.0031902591839539,0.0412181486566843,0.0341189824304964,"CD28/CD80",2
"R-HSA-9696270","R-HSA-9696270","RND2 GTPase cycle","3/78","43/10891",0.00354958651202911,0.0426271089667394,0.0352852718838254,"CKAP4/EPHA2/TFRC",3
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","5/78","143/10891",0.00356325678669339,0.0426271089667394,0.0352852718838254,"AGRN/CSPG4/HSPG2/OGN/SPON2",5
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","4/78","92/10891",0.00422437825225936,0.0454083158637873,0.0375874604184519,"EFNA1/EFNA4/EPHA2/EPHB4",4
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","3/78","46/10891",0.00429961230335929,0.0454083158637873,0.0375874604184519,"LTBP2/LTBP3/TGFBR2",3
"R-HSA-3656237","R-HSA-3656237","Defective EXT2 causes exostoses 2","2/78","14/10891",0.00435807365875358,0.0454083158637873,0.0375874604184519,"AGRN/HSPG2",2
"R-HSA-3656253","R-HSA-3656253","Defective EXT1 causes exostoses 1, TRPS2 and CHDS","2/78","14/10891",0.00435807365875358,0.0454083158637873,0.0375874604184519,"AGRN/HSPG2",2
